ARQT

Arcutis Biotherapeutics, Inc. Common Stock
Biotechnology·equity
$21.17
+2.47% today
Tapeline Score
43/ 100
Signal
NEUTRAL
71% data confidence

Congressional sells outnumber buys recently; below 50DMA with the 200DMA flattening; relative strength tilting up vs the sector.

TrendRSFundSMMacroMom43/ 100

Score breakdown · public formula

Trend
25% weight
20
Relative strength
20% weight
67
Fundamentals
15% weight
38
Smart money
15% weight
19
Macro
15% weight
61
Momentum
10% weight
73

Weights are public and never change without a changelog entry. Read the full methodology on /how-it-works.

See ARQT in the live scanner

Free signup gives you the score for the top 20 tickers, 24-hour delayed. 14-day Premium trial unlocks the full ~2,500-ticker live universe, smart alerts, congressional trades, and elite-fund 13F holdings.

Start 14-day Premium trial →See the public scorecardShare on X

Score updated live (sub-60s). Public formula. Public scorecard. Not investment advice — see risk disclosure.